T1	Participants 62 116	patients with implantable cardioverter defibrillators.
T2	Participants 260 321	patients with implantable cardioverter defibrillators (ICDs).
T3	Participants 710 722	172 patients
T4	Participants 843 862	patients with ICDs.
T5	Participants 863 1017	The majority of patients had a history of documented remote myocardial infarction and congestive heart failure New York Heart Association class II or III.
